Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Primary Melanoma to Metastatic Evolution: AI-Powered Pathology Integrated with Functional Analysis and Clinical Metadata Improving Treatment Prediction.

Cancers·2026
Same author

Absence of DNA viruses in ameloblastomas.

European journal of oral sciences·2026
Same author

Mechanisms of CARMIL dimerization, autoinhibition, and capping protein binding.

Science advances·2026
Same author

A Subphase-Labeled Mitotic Dataset for AI-powered Cell Division Analysis.

Scientific data·2026
Same author

LBR and LAP2 mediate heterochromatin tethering to the nuclear periphery to preserve genome homeostasis.

Nature cell biology·2026
Same author

A Proteomic Study of the Dual Oncogenic and Tumor-Suppressive Roles of SIRT3 in Lung and Breast Cancer Cell Lines.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Aug 30, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

895

Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer.

Juho Pirhonen1,2, Ábel Szkalisity1,2, Jaana Hagström3,4

  • 1Department of Anatomy and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Cancer Research
|September 2, 2022
PubMed
Summary
This summary is machine-generated.

Pancreatic cancer

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.9K
Dissection of the Mouse Pancreas for Histological Analysis and Metabolic Profiling
08:21

Dissection of the Mouse Pancreas for Histological Analysis and Metabolic Profiling

Published on: August 19, 2017

37.3K

Related Experiment Videos

Last Updated: Aug 30, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

895
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.9K
Dissection of the Mouse Pancreas for Histological Analysis and Metabolic Profiling
08:21

Dissection of the Mouse Pancreas for Histological Analysis and Metabolic Profiling

Published on: August 19, 2017

37.3K

Area of Science:

  • Oncology
  • Metabolomics
  • Proteomics

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer.
  • The tumor microenvironment is crucial for PDAC development.
  • Understanding metabolic communication in early PDAC is key for diagnosis and treatment.

Purpose of the Study:

  • To investigate metabolic differences between PDAC, adjacent benign tissues, and healthy pancreas.
  • To identify prognostic molecular changes in the tumor microenvironment.

Main Methods:

  • Deep proteomic analysis of laser-capture microdissected tissue compartments from PDAC patients.
  • Immunohistochemistry and nonlinear label-free imaging for validation.
  • Comparison with control pancreatic proteomes.

Main Results:

  • PDAC showed downregulated secretory function and high cholesterol biosynthesis.
  • Adjacent stromal compartments had abundant blood apolipoproteins.
  • Benign exocrine regions exhibited upregulated lipid transport proteins and poorer prognosis.

Conclusions:

  • Early PDAC exhibits distinct metabolic communication with its microenvironment.
  • Prognostic molecular changes, particularly in lipid metabolism, are present in non-cancerous adjacent tissue.
  • These changes may offer therapeutic targets.